Leslie spoke at this conference yesterday She was the second last speaker at the 8.04.45 mark.
Trust me, she was a breath of fresh air after a long day of very bland presentations. She was very positive and confident. Her presenting is a little jumbled at times but her passion and commitment can't be questioned. I wouldn't swap her for anyone. Leslie IS Imugene and I have no doubt she'll do whatever it takes to get these products to market and to patients that desperately need them.
Some interesting points: Yescarta was fully FDA approved form only 50 patients worth of data and sold to Gillead for 11 Billion US The first Azer Cell patient dosed in Aus at Royal Prince Alfred in January has had a complete response (not sure if that's one of the 4 from the latest announcement). Partnering with BP and the word cure were mentioned many times. They must be compiling some very compelling data.
I don't think we'll have much longer to wait for some significant announcements. Hopefully sensational data and a partnership to take us through to FDA approval and beyond. IMO. GLTAH
IMU Price at posting:
3.6¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)